![Anders Pedersen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Pedersen
Directeur des opérations chez
Galecto Biotech ApS
Profil
Anders H.
Pedersen was the founder of Profound Pharma AS, founded in 1999, where the title held was Director-Protein Chemistry from 1999 to 2009.
The current job is Chief Operating Officer at Galecto Biotech ApS, starting in 2013.
Former jobs include Manager-Projects & Department at Novo Nordisk A; Principal at The University of New Mexico from 1989 to 1990;.
Senior Vice President-Development at AGC Biologics A from 2010 to 2013; Chief Operating Officer at Recepticon ApS from 2006 to 2009; Manager-Project & Department at Biotech; Vice President-Portfolio Management at Life Cycle Pharma A from 2005 to 2006; and Chief Operating Officer at Galecto, Inc. from 2020 to 2026.
Education includes undergraduate studies at the Technical University of Denmark.
Postes actifs de Anders Pedersen
| Sociétés | Poste | Début |
|---|---|---|
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Directeur des opérations | 01/01/2013 |
Anciens postes connus de Anders Pedersen
| Sociétés | Poste | Fin |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Directeur des opérations | 05/01/2026 |
AGC Biologics A/S
 AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Corporate Officer/Principal | 01/03/2013 |
Recepticon ApS
 Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage | Directeur des opérations | 01/11/2009 |
Life Cycle Pharma A/S | Corporate Officer/Principal | 01/11/2006 |
The University of New Mexico
 The University of New Mexico Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1990 |
Formation de Anders Pedersen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Profound Pharma AS
 Profound Pharma AS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
The University of New Mexico
The University of New Mexico Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Health Technology |
Recepticon ApS
Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage | Health Technology |
Biotech
 Biotech BiotechnologyHealth Technology Manufactures biotechnical products | Health Technology |
Life Cycle Pharma A/S | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Choisissez Zonebourse 
